These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 9366158

  • 1. [Effects of pimobendan on pulmonary hypertension in patients with chronic pulmonary emphysema].
    Yamazaki Y, Matsumoto H, Takeda A, Takahashi T, Sasaki N, Takahashi M, Tsuji T, Fujikane T, Shimizu T.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Aug; 35(8):847-53. PubMed ID: 9366158
    [Abstract] [Full Text] [Related]

  • 2. [Effects of denopamine on hemodynamics and blood gases in secondary pulmonary hypertension].
    Ido A, Tsuji T, Shimizu T, Fukuzawa J, Fujiuchi S, Fujita Y, Ohki Y, Sasaki N, Sakai E, Onodera S.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Dec; 29(12):1553-9. PubMed ID: 1808377
    [Abstract] [Full Text] [Related]

  • 3. [Effects of low dose pimobendan in patients with cor-pulmonale].
    Nakatani M, Shirotani T, Kobayashi K, Satomi S, Ikeda Y, Kuniyoshi T, Tajiri E, Furuta Y, Motooka T.
    J Cardiol; 1999 Aug; 34(2):79-83. PubMed ID: 10466089
    [Abstract] [Full Text] [Related]

  • 4. [Acute hemodynamic effects of pimobendan and captopril: a comparative study in the same patients with chronic heart failure].
    Tsuda T, Izumi T, Kodama M, Hanawa H, Ohshima M, Takahashi M, Suzuki M, Aizaki T, Uchiyama H, Shibata A.
    J Cardiol; 1992 Aug; 22(4):721-9. PubMed ID: 1343639
    [Abstract] [Full Text] [Related]

  • 5. [Acute effect of milrinone on pulmonary hemodynamics in patients with hypoxic pulmonary hypertension].
    Cheng D, Chen W, Jiang J.
    Zhonghua Nei Ke Za Zhi; 1995 Apr; 34(4):256-9. PubMed ID: 7587607
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [The effects of oxygen and vasodilators on pulmonary hemodynamics and blood gases in chronic lung disease].
    Hirasima T, Matsumoto T, Hirata N, Kimura T, Fukuda K, Takenaka S, Shima K.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Sep; 30(9):1655-61. PubMed ID: 1447840
    [Abstract] [Full Text] [Related]

  • 8. Hemodynamic, neurohumoral, and myocardial energetic effects of pimobendan, a novel calcium-sensitizing compound, in patients with mild to moderate heart failure.
    Remme WJ, Kruijssen DA, van Hoogenhuyze DC, Krauss XH, Bartels GL, Storm CJ, de Leeuw PW.
    J Cardiovasc Pharmacol; 1994 Nov; 24(5):730-9. PubMed ID: 7532750
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Hemodynamic effects of inhaled nitric oxide and phosphodiesterase inhibitor (dipyridamole) on secondary pulmonary hypertension following heart valve surgery in adults.
    Santini F, Casali G, Franchi G, Auriemma S, Lusini M, Barozzi L, Favaro A, Messina A, Mazzucco A.
    Int J Cardiol; 2005 Aug 18; 103(2):156-63. PubMed ID: 16080974
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M, Plank C, Meissner U, Eberle KP, Weyand M, Cesnjevar R, Dötsch J, Rascher W.
    Pediatrics; 2006 Jul 18; 118(1):e76-84. PubMed ID: 16751617
    [Abstract] [Full Text] [Related]

  • 13. [Effects of diprophylline on pulmonary hypertension in patients with chronic pulmonary disease].
    Kang J.
    Zhonghua Jie He He Hu Xi Za Zhi; 1992 Jun 18; 15(3):153-4, 190. PubMed ID: 1473187
    [Abstract] [Full Text] [Related]

  • 14. Oral tadalafil in pulmonary artery hypertension: a prospective study.
    Aggarwal P, Patial RK, Negi PC, Marwaha R.
    Indian Heart J; 2007 Jun 18; 59(4):329-35. PubMed ID: 19126938
    [Abstract] [Full Text] [Related]

  • 15. Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension.
    Michelakis ED, Tymchak W, Noga M, Webster L, Wu XC, Lien D, Wang SH, Modry D, Archer SL.
    Circulation; 2003 Oct 28; 108(17):2066-9. PubMed ID: 14568893
    [Abstract] [Full Text] [Related]

  • 16. Differential systemic and pulmonary hemodynamic effects of L-arginine in patients with coronary artery disease or primary pulmonary hypertension.
    Böger RH, Mügge A, Bode-Böger SM, Heinzel D, Höper MM, Frölich JC.
    Int J Clin Pharmacol Ther; 1996 Aug 28; 34(8):323-8. PubMed ID: 8864793
    [Abstract] [Full Text] [Related]

  • 17. Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension: a randomized prospective study.
    Ghofrani HA, Voswinckel R, Reichenberger F, Olschewski H, Haredza P, Karadaş B, Schermuly RT, Weissmann N, Seeger W, Grimminger F.
    J Am Coll Cardiol; 2004 Oct 06; 44(7):1488-96. PubMed ID: 15464333
    [Abstract] [Full Text] [Related]

  • 18. Cardiovascular effects of sildenafil in neonates and infants with congenital diaphragmatic hernia and pulmonary hypertension.
    Noori S, Friedlich P, Wong P, Garingo A, Seri I.
    Neonatology; 2007 Oct 06; 91(2):92-100. PubMed ID: 17344658
    [Abstract] [Full Text] [Related]

  • 19. Vasodilatory treatment of pulmonary hypertension.
    Widimský J.
    Eur J Respir Dis; 1986 Mar 06; 68(3):161-6. PubMed ID: 2870937
    [Abstract] [Full Text] [Related]

  • 20. Mechanisms of a reduced cardiac output and the effects of milrinone and levosimendan in a model of infant cardiopulmonary bypass.
    Stocker CF, Shekerdemian LS, Nørgaard MA, Brizard CP, Mynard JP, Horton SB, Penny DJ.
    Crit Care Med; 2007 Jan 06; 35(1):252-9. PubMed ID: 17133188
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.